Interdisciplinary and individualized therapy of prostate cancer: International Prostate Cancer Symposium Bonn 2013 - challenges and targets - Abstract

Multimodal treatment of prostate cancer is based on specific staging via imaging, clinical parameters, tumor markers and histopathological grading.

Risk-adapted therapy encompasses wait and see, active surveillance, surgical intervention, radiotherapy and hormone therapy. Some patients also need a combination of these treatment options. Even though clinical parameters guide the treatment plan, patient wishes and preferences are incorporated. Against this background leading basic research scientists, urologists, radiotherapists, epidemiologists and members of other associated disciplines discussed state of the art treatment concepts, innovative trial designs and translational research projects at the international meeting "Challenges and Chances in Prostate Cancer Research" organized by the German Cancer Aid (Deutsche Krebshilfe).

Written by:
Schwardt M, Debus J, Feick G, Hadaschik B, Hohenfellner M, Schüle R, Zacharias JP, Combs SE.   Are you the author?
Urologie, Universitätsklinikum Freiburg, Freiburg, Deutschland.

Reference: Urologe A. 2014 Oct 10. Epub ahead of print.
doi: 10.1007/s00120-014-3580-7


PubMed Abstract
PMID: 25297487

Article in German.

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe